A new knee-surgery device investigated by University of Missouri-Columbia researchers that will help to repair meniscus tears, which were previously defined as irreparable, has been approved by the FDA for use in humans.
Men with certain scores and patterns based on prostate cancer biopsy were found to be at higher risk of PSA-failure, suggesting that this measurement could help predict the risk of prostate cancer recurrence, according to preliminary research published in the Oct. 3 issue of JAMA.
In people with chronic myeloid leukemia (CML), the drug Imatinib has been shown to drive cancer into remission, but the disease often returns when treatment is stopped. New research by UC Irvine scientists indicates that Imatinib could cure CML under certain circumstances if it is taken over a long enough period of time.
University of Manchester scientists will discuss their research aimed at reducing the side effects of radiotherapy without decreasing its effectiveness at the National Cancer Research Institute conference in Birmingham today Tuesday, Oct. 2, 2007.
A new drug has shown promising pre-clinical activity against cells from several types of children’s cancers, scientists reveal at the National Cancer Research Institute Conference in Birmingham.
When an adult suffers a cardiorespiratory arrest the rapid application of an electrical discharge with a defibrillator can avoid sudden death in many cases. Nevertheless, defibrillation also has its impediment or enemy: time. For every minute that passes from the moment of the attack, the possibilities of survival drop by 10%.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
One of the biggest problems in the current treatment of cancer is that the agents that are efficacious in the destruction of tumorous cells are, at the same time, extremely toxic for the rest of the healthy cells and tissues of the patient. To address the problem the University of the Basque Country (UPV/EHU) is seeking more specific treatments and studying the differences between tumorous cells and healthy ones.
Channel 4’s 4Talent and Cancer Research UK launch BREATHE on Monday 1 October 2007 – a joint initiative to produce a series of short online films to encourage young smokers to quit and deter others from starting. The competition launch coincides with new legislation making it illegal to sell tobacco products to people under the age of 18, an increase from 16.